Distinguishing benign from malignant gallbladder wall thickening using FDG-PET

Annals of Nuclear Medicine

Volumn 20, Issue 10, 2006, Pages 699-703

  Oe, Ai ^a   Kawabe, Joji ^a   Torii, Kenji ^a   Kawamura, Etsushi ^a   Higashiyama, Shigeaki ^a   Kotani, Jin ^a   Hayashi, Takehiro ^a   Kurooka, Hiroko ^a   Tsumoto, Chikako ^a   Kubo, Shoji ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FDG PET; Gallbladder cancer; Wall thickening

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CHOLECYSTITIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GALLBLADDER CANCER; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 33846522891     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984683     Document Type: Article

References (22)

1. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 2002; 38 (Suppl 5): S60-65.
2. 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003; 44: 198-206.
3. 18F]fluoro-2-deoxy- D-glucose. J Comput Assist Tomogr 1993; 17: 582-589.
4. Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004; 31: 590-595.
5. Kubota K. From rumor biology to clinical PET: A review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001; 15: 471-486.
6. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, et al. Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005; 11: 2785-2808.
7. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
8. Strauss LG. Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology. Oncologist 1997; 2: 381-388.
9. Kunishima S, Taniguchi H, Yamaguchi A, Koh T, Yamagishi H. Evaluation of Abdominal Tumors with [F-18]fluorodeoxyglucose positron emission tomography. Clin Positron Imaging 2000; 3: 91-96.
10. Rodriguez-Fernandez A, Gomez-Rio M, Llamas-Elvira JM, Ortega-Lozano S, Ferron-Orihuela JA, Ramia-Angel JM, et al. Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg 2004; 188: 171-175.
11. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8: 90-97.
12. Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluorodeoxyglucose (FDG-PET). J Surg Oncol 2003; 84: 74-81.
13. Shukla HS. Gallbladder cancer. J Surg Oncol 2006; 93: 604-606.
14. Rodriguez-Fernandez A, Gomez-Rio M, Medina-Benitez A, Moral JV, Ramos-Font C, Ramia-Angel JM. Application of modern imaging methods in diagnosis of gallbladder cancer. J Surg Oncol 2006; 93: 650-664.
15. Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006; 45: 43-50.
16. 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 2006; 47: 633-638.
17. Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kuhl H. Staging and follow-up of gastrointestinal tumors with PET/CT. Abdom Imaging 2006; 31: 25-35.
18. Chander S, Lee P, Zingas AP, Joyrich RN, Zak IT, Bloom DA. PET imaging of gallbladder carcinoma. Clin Nucl Med 2005; 30: 804-805.
19. Wakabayashi H, Akamoto S, Yachida S, Okano K, Izuishi K, Nishiyama Y. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture. Eur J Surg Oncol 2005; 31: 1175-1179.
20. Yoshimitsu K, Honda H, Jimi M, Kuroiwa T, Hanada K, Irie H. MR diagnosis of adenomyomatosis of the gallbladder and differentiation from gallbladder carcinoma: importance of showing Rokitansky-Aschoff sinuses. AJR 1999; 172: 1541-1546.
21. Hirooka Y, Naitoh Y, Goto H, Furukawa T, Ito A, Hayakawa T. Differential diagnosis of gall-bladder masses using colour Doppler ultrasonography. J Gastroenterol Hepatol 1996; 11: 840-846.
22. Yang HL, Sun YG, Wang Z. Polypoid lesions of the gallbladder: Diagnosis and indications for surgery. Br J Surg 1992; 229: 498-504.